TransMedics Group, Inc. (TMDX)
Automate Your Wheel Strategy on TMDX
With Tiblio's Option Bot, you can configure your own wheel strategy including TMDX - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol TMDX
- Rev/Share 14.4782
- Book/Share 7.8973
- PB 16.1689
- Debt/Equity 1.9467
- CurrentRatio 9.0988
- ROIC 0.0654
- MktCap 4320237922.0
- FreeCF/Share -1.875
- PFCF -68.329
- PE 87.9673
- Debt/Assets 0.619
- DivYield 0
- ROE 0.2188
- Rating B-
- Score 2
- Recommendation Sell
- P/E Score 1
- DCF Score 1
- P/B Score 1
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Downgrade | TMDX | JP Morgan | Overweight | Neutral | $116 | $75 | Dec. 17, 2024 |
| Initiation | TMDX | Robert W. Baird | -- | Outperform | -- | $200 | Sept. 24, 2024 |
| Initiation | TMDX | Needham | -- | Buy | -- | $208 | Aug. 21, 2024 |
News
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against TransMedics Group, Inc. (TMDX) And Encourages Investors to Reach Out
Published: May 29, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK CITY, NY / ACCESS Newswire / May 29, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of TransMedics Group, Inc. ("TransMedics" or "the Company") (NASDAQ:TMDX). Investors who purchased TransMedics securities prior to February 3, 2022, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/TMDX.
Read More
Reasons to Retain TransMedics Stock in Your Portfolio for Now
Published: May 23, 2025 by: Zacks Investment Research
Sentiment: Positive
TMDX continues to witness growth on the back of its strength in OCS technology and the National OCS Program.
Read More
TransMedics: Extremely Undervalued And Extremely Innovative
Published: May 21, 2025 by: Seeking Alpha
Sentiment: Positive
TransMedics delivered a stellar Q1, beating revenue and EPS estimates, and raised FY25 guidance, showcasing robust growth and execution. I see significant upside from expanding organ utilization, especially with the upcoming kidney market and international opportunities, which meaningfully increase TAM. Despite risks like share dilution, logistics complexity, and regulatory hurdles, TMDX's moat and growth trajectory remain compelling.
Read More
Earnings Estimates Moving Higher for TransMedics (TMDX): Time to Buy?
Published: May 15, 2025 by: Zacks Investment Research
Sentiment: Positive
TransMedics (TMDX) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Read More
What Makes TransMedics (TMDX) a New Buy Stock
Published: May 15, 2025 by: Zacks Investment Research
Sentiment: Positive
TransMedics (TMDX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Read More
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against TransMedics Group, Inc. (TMDX) And Encourages Shareholders to Reach Out
Published: May 15, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK, NY / ACCESS Newswire / May 15, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of TransMedics Group, Inc. ("TransMedics" or "the Company") (NASDAQ:TMDX). Investors who purchased TransMedics securities prior to February 3, 2022, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/TMDX.
Read More
TMDX Stock Gains Post Q1 Earnings & Revenue Beat, Gross Margin Down
Published: May 09, 2025 by: Zacks Investment Research
Sentiment: Positive
Increased organ utilization in liver and continued OCS adoption across both liver and heart boosted TransMedics' first-quarter 2025 performance.
Read More
TransMedics: Exceptional Q1 Undermines The Short Narrative
Published: May 09, 2025 by: Seeking Alpha
Sentiment: Positive
TransMedics reported extremely strong Q1 results, alleviating concerns from a weak Q3 2024 and a short attack in January. The company continues to expand its logistics capabilities and should see a boost from new heart and lung devices later in the year. While new perfusion devices are set to enter the market, TransMedics' competitive positioning appears to be extremely strong.
Read More
TransMedics Group, Inc. (TMDX) Q1 2025 Earnings Call Transcript
Published: May 08, 2025 by: Seeking Alpha
Sentiment: Neutral
TransMedics Group, Inc. (NASDAQ:TMDX ) Q1 2025 Earnings Conference Call May 8, 2025 4:30 PM ET Company Participants Laine Morgan - Gilmartin Group, Investor Relations Waleed Hassanein - President & Chief Executive Officer Gerardo Hernandez - Chief Financial Officer Conference Call Participants Allen Gong - JPMorgan Bill Plovanic - Canaccord Justin Wang - Morgan Stanley Chris Pasquale - Nephron Research Suraj Kalia - Oppenheimer David Rescott - Baird Mike Matson - Needham & Company Josh Jennings - TD Cowen Operator Good afternoon, and welcome to TransMedics First Quarter 2025 Earnings Conference Call. At this time, all participants are in a …
Read More
3 Mid-Cap Medical Stocks Outperforming the Market
Published: May 06, 2025 by: MarketBeat
Sentiment: Positive
While major market indexes like the S&P 500 have struggled to gain traction in 2025 and remain in the red YTD, certain pockets of the market are showing impressive strength. Several medical and biotechnology sector mid-cap stocks have stood out for their resilience and outperformance.
Read More
Insights Into TransMedics (TMDX) Q1: Wall Street Projections for Key Metrics
Published: May 05, 2025 by: Zacks Investment Research
Sentiment: Neutral
Get a deeper insight into the potential performance of TransMedics (TMDX) for the quarter ended March 2025 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
Read More
TransMedics Group, Inc. (TMDX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation
Published: April 24, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK, NY / ACCESS Newswire / April 24, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of TransMedics Group, Inc. ("TransMedics" or "the Company") (NASDAQ:TMDX). Investors who purchased TransMedics securities prior to February 3, 2022, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/TMDX.
Read More
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against TransMedics Group, Inc. (TMDX) and Encourages Stockholders to Learn More About the Investigation
Published: April 22, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK, NY / ACCESS Newswire / April 22, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of TransMedics Group, Inc. ("TransMedics" or "the Company") (NASDAQ:TMDX). Investors who purchased TransMedics securities prior to February 3, 2022, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/TMDX.
Read More
Scott+Scott Attorneys at Law LLP Reminds Investors that It is Investigating Ibotta, Inc. (NYSE: IBTA)
Published: April 18, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, April 18, 2025 (GLOBE NEWSWIRE) -- Scott+Scott Attorneys at Law LLP (“Scott+Scott”), a shareholder and consumer rights litigation firm, is investigating whether Ibotta, Inc. (“Ibotta” or the “Company”) (NYSE: IBTA) or certain of its officers and directors issued misleading and false statements and/or failed to disclose information material to investors in violation of federal securities laws.
Read More
Levi & Korsinsky Notifies Shareholders of TransMedics Group, Inc.(TMDX) of a Class Action Lawsuit and an Upcoming Deadline
Published: April 15, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK, NY / ACCESS Newswire / April 15, 2025 / If you suffered a loss on your TransMedics Group, Inc. (NASDAQ:TMDX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/transmedics-group-inc-lawsuit-submission-form-2?prid=143173&wire=1 or contact Joseph E. Levi, Esq.
Read More
Shareholders of TransMedics Group, Inc. Should Contact Levi & Korsinsky Before April 15, 2025 to Discuss Your Rights - TMDX
Published: April 15, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK, NY / ACCESS Newswire / April 15, 2025 / If you suffered a loss on your TransMedics Group, Inc. (NASDAQ:TMDX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/transmedics-group-inc-lawsuit-submission-form-2?prid=143156&wire=1 or contact Joseph E. Levi, Esq.
Read More
TMDX Deadline Today: Rosen Law Firm Encourages TransMedics Group, Inc. Investors to Secure Counsel Before Important April 15 Deadline in Securities Class Action First Filed by the Firm – TMDX
Published: April 15, 2025 by: Business Wire
Sentiment: Neutral
NEW YORK--(BUSINESS WIRE)--Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of TransMedics Group, Inc. (NASDAQ: TMDX) between February 28, 2023 and January 10, 2025, both dates inclusive (the “Class Period”), of the important April 15, 2025 lead plaintiff deadline in the securities class action first filed by the Firm. So what: If you purchased TransMedics securities during the Class Period you may be entitled to compensation without payment of any out of.
Read More
TMDX DEADLINE TODAY: ROSEN, THE FIRST FILING FIRM, Encourages TransMedics Group, Inc. Investors to Secure Counsel Before Important April 15 Deadline in Securities Class Action First Filed by the Firm – TMDX
Published: April 15, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, April 15, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of TransMedics Group, Inc. (NASDAQ: TMDX) between February 28, 2023 and January 10, 2025, both dates inclusive (the “Class Period”), of the important April 15, 2025 lead plaintiff deadline in the securities class action first filed by the Firm.
Read More
Class Action Filed Against TransMedics Group, Inc. (TMDX) - April 15, 2025 Deadline to Join - Contact Levi & Korsinsky
Published: April 14, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK, NY / ACCESS Newswire / April 14, 2025 / If you suffered a loss on your TransMedics Group, Inc. (NASDAQ:TMDX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/transmedics-group-inc-lawsuit-submission-form-2?prid=142991&wire=1 or contact Joseph E. Levi, Esq.
Read More
TMDX DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages TransMedics Group, Inc. Investors to Secure Counsel Before Important April 15 Deadline in Securities Class Action First Filed by the Firm - TMDX
Published: April 14, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK CITY, NY / ACCESS Newswire / April 14, 2025 / WHY: New York, N.Y., April 14, 2025.
Read More
TransMedics Group, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before April 15, 2025 to Discuss Your Rights - TMDX
Published: April 14, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK, NY / ACCESS Newswire / April 14, 2025 / If you suffered a loss on your TransMedics Group, Inc. (NASDAQ:TMDX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/transmedics-group-inc-lawsuit-submission-form-2?prid=142980&wire=1 or contact Joseph E. Levi, Esq.
Read More
Class Action Filed Against TransMedics Group, Inc. (TMDX) Seeking Recovery for Investors - Contact Levi & Korsinsky
Published: April 14, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK, NY / ACCESS Newswire / April 14, 2025 / If you suffered a loss on your TransMedics Group, Inc. (NASDAQ:TMDX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/transmedics-group-inc-lawsuit-submission-form-2?prid=142940&wire=1 or contact Joseph E. Levi, Esq.
Read More
Scott+Scott Attorneys at Law LLP Files Securities Class Action Against Treace Medical Concepts, Inc. (NASDAQ: TMCI)
Published: April 11, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, April 11, 2025 (GLOBE NEWSWIRE) -- Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international shareholder and consumer rights litigation firm, has filed a securities class action lawsuit in the United States District Court for the Middle District of Florida against Treace Medical Concepts, Inc. (“Treace Medical” or the “Company”) (NASDAQ: TMCI), and certain of its former and current officers and/or directors (collectively, “Defendants”). The Class Action asserts claims under §§10(b) and 20(a) of the Securities Exchange Act of 1934 (15 U.S.C. §§78j(b) and 78t(a)) and U.S. Securities and Exchange Commission Rule 10b-5 promulgated thereunder (17 C.F.R. §240.10b-5) on …
Read More
TransMedics Group, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before April 15, 2025 to Discuss Your Rights - TMDX
Published: April 11, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK, NY / ACCESS Newswire / April 11, 2025 / If you suffered a loss on your TransMedics Group, Inc. (NASDAQ:TMDX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/transmedics-group-inc-lawsuit-submission-form-2?prid=142568&wire=1 or contact Joseph E. Levi, Esq.
Read More
Class Action Filed Against TransMedics Group, Inc. (TMDX) Seeking Recovery for Investors - Contact Levi & Korsinsky
Published: April 11, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK, NY / ACCESS Newswire / April 11, 2025 / If you suffered a loss on your TransMedics Group, Inc. (NASDAQ:TMDX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/transmedics-group-inc-lawsuit-submission-form-2?prid=142566&wire=1 or contact Joseph E. Levi, Esq.
Read More
Levi & Korsinsky Reminds TransMedics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 15, 2025 - TMDX
Published: April 11, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK, NY / ACCESS Newswire / April 11, 2025 / If you suffered a loss on your TransMedics Group, Inc. (NASDAQ:TMDX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/transmedics-group-inc-lawsuit-submission-form-2?prid=142514&wire=1 or contact Joseph E. Levi, Esq.
Read More
Levi & Korsinsky Reminds TransMedics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 15, 2025 - TMDX
Published: April 10, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK, NY / ACCESS Newswire / April 10, 2025 / If you suffered a loss on your TransMedics Group, Inc. (NASDAQ:TMDX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/transmedics-group-inc-lawsuit-submission-form-2?prid=142294&wire=1 or contact Joseph E. Levi, Esq.
Read More
TransMedics Group, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before April 15, 2025 to Discuss Your Rights - TMDX
Published: April 10, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK, NY / ACCESS Newswire / April 10, 2025 / If you suffered a loss on your TransMedics Group, Inc. (NASDAQ:TMDX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/transmedics-group-inc-lawsuit-submission-form-2?prid=142284&wire=1 or contact Joseph E. Levi, Esq.
Read More
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of TransMedics Group
Published: April 10, 2025 by: PRNewsWire
Sentiment: Neutral
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In TransMedics To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in TransMedics between February 23, 2023 and January 10, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK , April 10, 2025 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against TransMedics Group, Inc. ("TransMedics" or the …
Read More
TransMedics Group, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before April 15, 2025 to Discuss Your Rights - TMDX
Published: April 10, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK, NY / ACCESS Newswire / April 10, 2025 / If you suffered a loss on your TransMedics Group, Inc. (NASDAQ:TMDX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/transmedics-group-inc-lawsuit-submission-form-2?prid=142261&wire=1 or contact Joseph E. Levi, Esq.
Read More
About TransMedics Group, Inc. (TMDX)
- IPO Date 2019-05-02
- Website https://www.transmedics.com
- Industry Medical - Devices
- CEO Dr. Waleed H. Hassanein M.D.
- Employees 728